Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity?
暂无分享,去创建一个
[1] D. Cutler,et al. Numerical deconvolution by least squares: Use of prescribed input functions , 1978, Journal of Pharmacokinetics and Biopharmaceutics.
[2] I. Wilding,et al. Colonic transit of different sized tablets in healthy subjects , 1993 .
[3] D N Wheatley,et al. Intracellular transport mechanisms: a critique of diffusion theory. , 1995, Journal of theoretical biology.
[4] H. Stanley,et al. Fractal growth viscous fingers: quantitative characterization of a fluid instability phenomenon , 1985, Nature.
[5] N. Modi,et al. Optimal extravascular dosing intervals , 1991, Journal of Pharmacokinetics and Biopharmaceutics.
[6] Gordon L. Amidon,et al. Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.
[7] Nobuo Aoyagi,et al. Estimation of Agitation Intensity in the GI Tract in Humans and Dogs Based on in Vitro/in Vivo Correlation , 1995, Pharmaceutical Research.
[8] D. Cutler. Numerical deconvolution by least squares: Use of polynomials to represent the input function , 1978, Journal of Pharmacokinetics and Biopharmaceutics.
[9] D. Wheatley. Diffusion theory in biology: its validity and relevance , 1993 .
[10] M. Shameem,et al. Oral Solid Controlled Release Dosage Forms: Role of GI-Mechanical Destructive Forces and Colonic Release in Drug Absorption Under Fasted and Fed Conditions in Humans , 1995, Pharmaceutical Research.
[11] S. Davis,et al. Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .
[12] Peter Veng-Pedersen,et al. An algorithm and computer program for deconvolution in linear pharmacokinetics , 1980, Journal of Pharmacokinetics and Biopharmaceutics.
[13] S. Gull,et al. Maximum entropy and its application to the calculation of drug absorption rates , 1987, Journal of Pharmacokinetics and Biopharmaceutics.
[14] L S Liebovitch,et al. Fractal model of ion-channel kinetics. , 1987, Biochimica et biophysica acta.
[15] G. Digenis,et al. Gamma scintigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms. , 1991, Critical reviews in therapeutic drug carrier systems.
[16] Panos Macheras,et al. A Fractal Approach to Heterogeneous Drug Distribution: Calcium Pharmacokinetics , 1996, Pharmaceutical Research.
[17] Hans Lennernäs,et al. EXPERIMENTAL ESTIMATION OF THE EFFECTIVE UNSTIRRED WATER LAYER THICKNESS IN THE HUMAN JEJUNUM, AND ITS IMPORTANCE IN ORAL-DRUG ABSORPTION , 1995 .
[18] Bradley S. Turner,et al. Viscous fingering of HCI through gastric mucin , 1992, Nature.
[19] I. Wilding,et al. Scintigraphic and pharmacokinetic assessment of a multiparticulate sustained release formulation of diltiazem , 1991 .
[20] W. Hauck,et al. Absorption Rate Vs. Exposure: Which Is More Useful for Bioequivalence Testing? , 1996, Pharmaceutical Research.
[21] Michael F. Shlesinger,et al. Time‐Scale Invariance in Transport and Relaxation , 1991 .
[22] J. Bassingthwaighte,et al. Fractal Nature of Regional Myocardial Blood Flow Heterogeneity , 1989, Circulation research.
[23] J. Dressman,et al. Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.
[24] Raoul Kopelman,et al. Fractal Reaction Kinetics , 1988, Science.
[25] T. Macgregor,et al. The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man , 1974, Journal of Pharmacokinetics and Biopharmaceutics.
[26] W. Cannon,et al. The mechanical factors of digestion , 1911 .
[27] L. Holm,et al. Microscopy of acid transport at the gastric surface in vivo , 1990, Journal of internal medicine. Supplement.
[28] Lawrence X. Yu,et al. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .
[29] Gérard Daccord. Chemical dissolution of a porous medium by a reactive fluid. , 1987 .
[30] B. Krevsky,et al. Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans. , 1986, Gastroenterology.
[31] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[32] Davide Verotta,et al. Two constrained deconvolution methods using spline functions , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[33] M. Spino,et al. High Variability in Drug Pharmacokinetics Complicates Determination of Bioequivalence: Experience with Verapamil , 1996, Pharmaceutical Research.
[34] Patrick J. Sinko,et al. Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach , 1991, Pharmaceutical Research.
[35] G. Daccord,et al. Fractal patterns from chemical dissolution , 1987, Nature.
[36] L. C. Feely,et al. Gastrointestinal transit of non-disintegrating tablets in fed subjects , 1989 .
[37] R. Spiller,et al. Emptying of the terminal ileum in intact humans: Influence of meal residue and ileal motility , 1987 .
[38] Bruce J. West,et al. Fractal physiology , 1994, IEEE Engineering in Medicine and Biology Magazine.